                         SEQUENCE LISTING

<110>  Bionomics
 
<120>  Method of Monitoring Response to a Treatment

<130>  35524502

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Heavy Chain CDR1

<400>  1

Gly Tyr Ser Phe Thr Ala Tyr Trp 
1               5               


<210>  2
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Heavy Chain CDR2

<400>  2

Ile Leu Pro Gly Ser Asp Ser Thr 
1               5               


<210>  3
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Heavy Chain CDR3

<400>  3

Ala Arg Ser Gly Tyr Tyr Gly Ser Ser Gln Tyr 
1               5                   10      


<210>  4
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ESVDSYGNSF

<400>  4

Glu Ser Val Asp Ser Tyr Gly Asn Ser Phe 
1               5                   10  


<210>  5
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Light Chain CDR2

<400>  5

Leu Thr Ser 
1           


<210>  6
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Light Chain CDR3

<400>  6

Gln Gln Asn Ala Glu Asp Pro Arg Thr 
1               5                   


<210>  7
<211>  137
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Heavy Chain Variable Domain

<400>  7

Met Glu Trp Ser Trp Val Phe Leu Phe Phe Leu Ser Val Thr Thr Gly 
1               5                   10                  15      


Val His Ser Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys 
            20                  25                  30          


Pro Gly Glu Ser Leu Arg Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe 
        35                  40                  45              


Thr Ala Tyr Trp Ile Glu Trp Val Arg Gln Ala Pro Gly Lys Gly Leu 
    50                  55                  60                  


Glu Trp Ile Gly Glu Ile Leu Pro Gly Ser Asp Ser Thr Asn Tyr Asn 
65                  70                  75                  80  


Glu Lys Phe Lys Gly His Val Thr Ile Ser Ala Asp Lys Ser Ile Ser 
                85                  90                  95      


Thr Ala Tyr Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Val 
            100                 105                 110         


Tyr Tyr Cys Ala Arg Ser Gly Tyr Tyr Gly Ser Ser Gln Tyr Trp Gly 
        115                 120                 125             


Gln Gly Thr Leu Val Thr Val Ser Ser 
    130                 135         


<210>  8
<211>  131
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Light Chain Variable Domain

<400>  8

Met Ser Val Pro Thr Gln Val Leu Gly Leu Leu Leu Leu Trp Leu Thr 
1               5                   10                  15      


Asp Ala Arg Cys Asp Ile Val Leu Thr Gln Ser Pro Ala Ser Leu Ala 
            20                  25                  30          


Val Ser Pro Gly Gln Arg Ala Thr Ile Thr Cys Arg Ala Ser Glu Ser 
        35                  40                  45              


Val Asp Ser Tyr Gly Asn Ser Phe Met His Trp Tyr Gln Gln Lys Pro 
    50                  55                  60                  


Gly Gln Pro Pro Lys Leu Leu Ile Tyr Leu Thr Ser Asn Leu Glu Ser 
65                  70                  75                  80  


Gly Val Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
                85                  90                  95      


Leu Thr Ile Asn Pro Val Glu Ala Asn Asp Ala Ala Thr Tyr Tyr Cys 
            100                 105                 110         


Gln Gln Asn Ala Glu Asp Pro Arg Thr Phe Gly Gly Gly Thr Lys Leu 
        115                 120                 125             


Glu Ile Lys 
    130     


